Anbio Biotechnology Class A Ordinary Shares (NNNN) Stock

Anbio Biotechnology Class A Ordinary Shares (NNNN) is a Healthcare stock trading at $16.60 (as of 2026-06-18), with a market capitalization of $1.50B and a trailing P/E of 234.1. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Anbio Biotechnology develops and supplies in vitro diagnostic products, including SARS‑CoV‑2 antigen rapid tests and SARS‑CoV‑2/influenza A/B antigen rapid tests, along with related assay platforms such as lateral flow and fluorescence immunoassays, loop‑mediated isothermal amplification, chemiluminescence immunoassays, and RT‑PCR. Its diagnostics are sold across multiple regions including the European Union, Asia Pacific, and the Americas, serving point‑of‑care, over‑the‑counter, and laboratory testing markets.

Valuation — source: SEC EDGAR (first-party)
Price$16.60
Market Cap$1.50B
P/E Ratio234.1
Price / Book49.83
Price / Sales173.79
DCF Value (model)$-2.45
DCF Upside vs Price-114.8%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$8.65M
Net Margin74.1%
Return on Equity21.2%
Current Ratio344.31
Revenue Growth (YoY)5.6%
EPS Growth (YoY)162.5%
Financial Health — source: SEC EDGAR
Altman Z-Score4955.31 (safe)
Valuation vs Sector & Industry
Stock P/E234.1
Sector P/E (Healthcare)21.0
Industry P/E (Pharmaceutical Products)17.3
vs Sector1016.8%
vs Industry1256.1%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderGEODE CAPITAL MANAGEMENT, LLC ($661851.00)
Institutional Holders Tracked9
Company
SectorHealthcare
IndustryPharmaceutical Products
CEOMichael Lau
Employees27
CountryDE
IPO Date2025-02-19

Related Companies (Business model: Clinical Labs / CRO Services; 8 closest by market cap; US-domiciled)

  • Celldex Therapeutics, Inc. (CLDX)
  • BillionToOne, Inc. (BLLN)
  • Fortrea Holdings Inc. (FTRE)
  • Neogen Corporation (NEOG)
  • Castle Biosciences, Inc. (CSTL)
  • CareDx, Inc (CDNA)
  • Fulgent Genetics, Inc. (FLGT)
  • Personalis, Inc. (PSNL)
NNNN earnings history · NNNN institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.